[S2] Radiopharmaceutical Sciences

10:25 AM - 10:45 AM JST(1:25 AM - 1:45 AM UTC)

[S2-03*] Developing robust targetry and radiochemistry of antimony-119 for pre-clinical applications in radioligand therapy

*Aivija Grundmane^1,2, Caterina F Ramogida^1,2, Valery Radchenko^2,3 (1. Simon Fraser University (Canada), 2. TRIUMF (Canada), 3. University of British Columbia (Canada))

Keywords:

antimony-119,radioligand therapy,radiopharmaceuticals,radionuclide production,electroplating